SMAD3 and Parkinson disease: Furthermore, SIS3 not only significantly enhanced the levels of proinflammatory factors but also significantly aggravated the LPS-induced proinflammatory factor level increase in microglia cultures, which are consistent with our in vivo results and further support the role of Smad3 signaling deficiency in PD neurodegeneration.